France to start producing coronavirus vaccines at four labs amid pressure to speed up innoculations

Emmanuel Macron says jabs must also be supplied to poorer developing countries

French President Emmanuel Macron adjusts his face mask on the sidelines of a working lunch on February 3, 2021 at The Elysee Presidential Palace in Paris (AFP via Getty Images)

France will soon begin production coronavirus vaccines from four laboratories, the president has said, as the country faces pressure to speed up inoculations.

Emmanuel Macron said all French people who are willing to be vaccinated against the virus will be offered a jab by the end of the summer.

In an interview with TF1 television, Mr Macron also said that because the virus is evolving quickly, pharmaceutical companies need to start preparing now for vaccines that will be needed by winter and early next year.

He added that vaccines must also be supplied to poorer developing countries, notably those in Africa and Latin America.

"We must think about developing countries because if we do not vaccinate there too, the virus will circulate there and mutate, and it will strike unjustly the poorest people, and then the virus will come back to our countries."

Mr Macron said the major constraint today was not intellectual property but production capacity and that companies who invented the vaccines must link up with those who can help them boost output, while respecting intellectual property rights.

" We are now converting sites in Europe to produce vaccines. [French pharmaceutical company] Sanofi will convert a site in Germany in coming months to produce [Covid-19 vaccines]," he said.

He added that the 27-nation European Union so far had ordered a supply of about 2.4 billion vaccines. Some EU member states have sharply criticised the slow rollout of vaccination programmes within the bloc.

Asked about Russia's Sputnik V vaccine, Mr Macron said that a few weeks ago he had sent a scientific mission to Russia and the exchanges were positive, and that there had been reports indicating the shot was effective against Covid-19.

"But in order to approve a vaccine, a request to market it must first be made. The minute a request is made, European and national authorities will study this independently and, depending on the results, approve it or not. It is not a political decision but a scientific decision," he said.